We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

83 hedge funds and large institutions have $892M invested in Enfusion, Inc. in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $1.99M | Put options by funds: $981K

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

33% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 24

10% more capital invested

Capital invested by funds: $813M → $892M (+$78.6M)

8% less funds holding

Funds holding: 9083 (-7)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
83
Holders Change
-7
Holders Change %
-7.78%
% of All Funds
1.3%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
16
Increased
32
Reduced
24
Closed
23
Calls
$1.99M
Puts
$981K
Net Calls
+$1.01M
Net Calls Change
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
101
Point72 Asset Management
Connecticut
-$87.9K -8,368 Closed
QT
102
Quantbot Technologies
New York
-$75.6K -7,201 Closed
Lazard Asset Management
103
Lazard Asset Management
New York
-$27K -2,605 Closed
QL
104
Quarry LP
New York
-$19.5K -1,856 Closed
PMEF
105
Point72 Middle East FZE
United Arab Emirates
-$16.7K -1,586 Closed
TWA
106
TCI Wealth Advisors
Arizona
-$3.75K -357 Closed

ENFN Hedge Fund Activity: Q2 2023 in Review

83 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q2 2023, worth a combined $892M — up 9.7% from $813M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ENFN and 16 opened new positions — a net loss of 7 holders — while 24 trimmed existing stakes and 32 added.

The largest buyer was Vanguard Group, adding an estimated $11.5M. The largest seller was Dragoneer Investment Group, exiting entirely with an estimated $44.3M sold.

  • 83 institutional investors held Enfusion, Inc. (ENFN) as of Q2 2023, down from 90 in Q1 2023.
  • Funds reported $892M of Enfusion, Inc. stock for Q2 2023, up 9.7% quarter-over-quarter.
  • 16 funds opened new Enfusion, Inc. positions in Q2 2023 and 23 closed out, a net change of -7 holders.
  • The largest Enfusion, Inc. buyer in Q2 2023 was Vanguard Group, an estimated $11.5M added.
  • The largest Enfusion, Inc. seller in Q2 2023 was Dragoneer Investment Group, an estimated $44.3M sold.

Based on aggregated 13F filings for Q2 2023.